BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25496649)

  • 21. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
    Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression.
    Kanda N; Watanabe S
    J Invest Dermatol; 2004 Aug; 123(2):319-28. PubMed ID: 15245432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
    Hinsche O; Girgert R; Emons G; Gründker C
    Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
    Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
    Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
    PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells.
    Lappano R; Rosano C; De Marco P; De Francesco EM; Pezzi V; Maggiolini M
    Mol Cell Endocrinol; 2010 May; 320(1-2):162-70. PubMed ID: 20138962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression.
    Kanda N; Watanabe S
    J Invest Dermatol; 2003 Dec; 121(6):1500-9. PubMed ID: 14675202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
    Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
    Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 17β-Estradiol on Mitophagy in the Murine MC3T3-E1 Osteoblast Cell Line is Mediated via G Protein-Coupled Estrogen Receptor and the ERK1/2 Signaling Pathway.
    Sun X; Yang X; Zhao Y; Li Y; Guo L
    Med Sci Monit; 2018 Feb; 24():903-911. PubMed ID: 29438359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.
    Haas E; Meyer MR; Schurr U; Bhattacharya I; Minotti R; Nguyen HH; Heigl A; Lachat M; Genoni M; Barton M
    Hypertension; 2007 Jun; 49(6):1358-63. PubMed ID: 17452498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Doses of Nonylphenol Promote Growth of Colon Cancer Cells through Activation of ERK1/2 via G Protein‒Coupled Receptor 30.
    Xie M; Liang JL; Huang HD; Wang MJ; Zhang T; Yang XF
    Cancer Res Treat; 2019 Oct; 51(4):1620-1631. PubMed ID: 31096733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P; Pang Y; Filardo EJ; Dong J
    Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of ERβ and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen.
    Huang W; Chen Y; Liu Y; Zhang Q; Yu Z; Mou L; Wu H; Zhao L; Long T; Qin D; Gui Y
    Biomed Res Int; 2015; 2015():251780. PubMed ID: 26090392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol and raloxifene induce the proliferation of osteoblasts through G-protein-coupled receptor GPR30.
    Noda-Seino H; Sawada K; Hayakawa J; Ohyagi-Hara C; Mabuchi S; Takahashi K; Nishio Y; Sakata M; Kurachi H; Kimura T
    J Endocrinol Invest; 2013 Jan; 36(1):21-7. PubMed ID: 22453024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.